If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
114.00    3.50 (3.17%)
Bid:
109.00
Ask:
110.00
Spread: 1.00 (0.917%)
Market Cap: £112.35m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

Acquisition

9 Mar 2016 07:00

RNS Number : 4738R
Eurocell plc
09 March 2016
 

9 March 2016

 

Eurocell plc

Acquisition of Vista Panels Ltd

 

Eurocell plc ("Eurocell" or the "Company"), the leading sustainable B2B supplier of PVC building products with its own distribution network is pleased to announce it has signed an agreement for the acquisition of Vista Panels Ltd ("Vista") from CorpAcq Limited. The consideration for the acquisition is £7.1m, on a debt free, cash free basis, to be funded from existing bank facilities and is expected to be earnings enhancing in the first full year of ownership.

About Vista

Headquartered in the Wirral, United Kingdom, Vista is a leading manufacturer of composite and PVC-U entrance doors and has been a leader in the growth of the composite doors market in the UK, with a strong presence in the social housing and private RMI sectors. It is currently the sole supplier of entrance doors to Eurocell and a significant consumer of Eurocell's profile products. The Company currently employs over 100 people nationwide. In the year ended 31 December 2015, Vista generated revenue of £13.7m. The earnings before interest and tax were £1.4m and gross assets were £3.9 million.

It is expected that Vista will continue to operate as a standalone business in the Wirral under the Vista brand. The current management team will remain with Vista.

Patrick Bateman, Chief Executive Officer, commented: "The acquisition will broaden the routes to market for Vista in particular to the new build sector, and provide opportunity for cross selling into the respective customer bases. We know the business well, having worked with them both as a customer and a supplier. It's logical, therefore, that we wanted them to join forces with us. Together we have a stronger proposition in markets strategically important to both businesses." 

 

Enquiries:

Teneo Strategy +44 (0) 20 3603 5220

Ben Foster

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQSSEEFAFMSEED
Date   Source Headline
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20246:00 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSNon-executive Directors' Share Purchase Plan
1st Feb 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:04 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSDirectorate Change
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSYear End Trading Update
23rd Jan 20247:00 amRNSLaunch of Share Buyback Programme
27th Dec 20237:00 amRNSHolding(s) in Company
19th Dec 20234:30 pmRNSHolding(s) in Company
29th Nov 20234:30 pmRNSDirector/PDMR Shareholding
14th Nov 20234:30 pmRNSDirector/PDMR Shareholding
3rd Nov 20234:30 pmRNSHolding(s) in Company
2nd Nov 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20234:30 pmRNSHolding(s) in Company
16th Oct 20234:30 pmRNSDirector/PDMR Shareholding
13th Oct 20234:30 pmRNSHolding(s) in Company
22nd Sep 20237:00 amRNSInvestor Presentation
21st Sep 20234:30 pmRNSDirector/PDMR Shareholding
7th Sep 20236:30 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSHalf-year Results
4th Sep 20237:00 amRNSBlock listing Interim Review
9th Aug 20234:30 pmRNSDirector/PDMR Shareholding
25th Jul 20237:00 amRNSTrading Update - In Line with Expectations
17th Jul 20237:00 amRNSHolding(s) in Company
18th May 20237:00 amRNSHolding(s) in Company
16th May 20234:00 pmRNSHolding(s) in Company
16th May 20237:00 amRNSHolding(s) in Company
15th May 20235:00 pmRNSChanges to Board Committee Memberships
12th May 20237:00 amRNSTrading Update and Board Changes
11th May 20234:30 pmRNSResult of AGM
10th May 20237:00 amRNSDirector/PDMR Shareholding
24th Apr 20237:00 amRNSDirector/PDMR Shareholding
17th Apr 20237:00 amRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.